A new study has found that adults with depression who start treatment with newer antipsychotic medications may face a higher ...

Up to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing ...

Legislation requiring healthcare professionals assess a woman for postpartum depression made it over the first hurdles last ...

Over 30 million Americans take antidepressants. Researchers found four specific types with ties to cognition loss later in life.

Sooma Oy secured U.S. FDA investigational device exemption approval to initiate a pivotal study of its transcranial direct ...

An abundance of data show that SSRIs, a class of drugs commonly used as antidepressants, are effective, though, like any drug, they have risks.

A study of people who started ADHD stimulant treatment via telehealth vs in-person visits shows no difference in risk of new substance use disorders except for young adults age 26-34.

Sooma announced that it received FDA investigational device exemption (IDE) for its transcranial direct current stimulation ...

A Greenwood Village mental health clinic said they are the first to provide ketamine therapy that they say is affordable to ...

The latest health news includes Johnson & Johnson halting testing on a depression drug, USDA eliminating food safety advisory ...

This summary highlights key global health developments, including J&J halting studies of a depression drug due to low ...

Johnson & Johnson JNJ decided to discontinue the Phase 3 VENTURA development program, which is evaluating aticaprant as an ...